Which medication requires that clients be monitored for potential side effects related to dry mouth?

Carbamazepine is known to cause dry mouth as a common side effect, which makes monitoring necessary for patients taking this medication. Dry mouth, or xerostomia, can occur due to the anticholinergic effects associated with Carbamazepine's mechanism of action. This side effect can lead to discomfort and can increase the risk of dental problems if not managed properly.

Patients on Carbamazepine should be educated on oral hygiene practices, and healthcare providers should regularly assess for this side effect throughout the course of treatment. Recognizing and addressing dry mouth can help improve the overall quality of life for patients taking this medication.